Enterprise Solutions Webinars

  1. Designing Drug Substance Processes For Fill-Finish Compatibility 2/4/2026

    Integrated KBI and Argonaut solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.

  2. The Power Of People: How A Stable, Experienced Team Drives CDMO Success 2/3/2026

    This message highlights a CDMO site’s commitment to quality, safety, excellence, experienced staff, stable workforce, and seamless clinical‑to‑commercial transfer to support client success.

  3. Viral Clearance Strategies For Monoclonal Antibodies And Proteins 1/30/2026

    Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.

  4. Simplified Harvest And Media Exchange In Cell Therapy 1/28/2026

    Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

  5. A Trusted New Partnership 1/28/2026

    Optima delivers high‑quality, flexible syringe and vial filling solutions with fast qualification, U.S.‑based support, and long‑term partnership reliability, helping CDMOs scale efficiently and confidently.

  6. Putting Pressure On CDMOs With Herman Bozenhardt 1/27/2026

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Herman Bozenhardt, a consultant and industry veteran who has spent decades advancing the fields of biopharmaceutical manufacturing, engineering, and regulatory compliance.

  7. Commercially Proven Sterile Fill/Finish With Capacity And Global Backing 1/27/2026

    Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

  8. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  9. Understanding Surfactant Excipients In Biologic Formulations 1/26/2026

    Uncover surfactant characterization, polysorbate degradation, and advanced analytics, such as multidimensional LC, to strengthen stability assessment and formulation for biologics and advanced therapies.

  10. Subvisible Particle Analysis For End‑To‑End Quality 1/26/2026

    See strategies for precise subvisible particle analysis, covering regulatory expectations, method validation, and controlling variability when transitioning workflows from R&D to GMP environments.